Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension

Ivana Zavaroni, Diego Ardigò, Alessandra Zuccarelli, Edoarda Pacetti, Pier M. Piatti, Lucilla Monti, Silvia Valtueña, Paola Massironi, Pier C. Rossi, Gerald M. Reaven

Research output: Contribution to journalArticle

Abstract

Background and aim: Approximately 50% of subjects with essential hypertension (EH) are insulin resistant, and this defect in insulin action could contribute to increased cardiovascular disease (CVD) risk in these patients. To test this hypothesis, we attempted to see if there was a link between insulin resistance (IR) and carotid intimal medial thickness (IMT), an early index of CVD, in patients with essential hypertension. Methods and results: Ultrasound quantification of carotid IMT was performed in 79 hypertensive patients, and 63 patients (31 m and 32 f), defined as being free of plaque (IMT <1.3 mm), were further subdivided into normal (<1.0 mm) and thickened (1-1.3 mm) IMT groups. Subjects in the thickened IMT group were older and had significantly (p <0.05) higher plasma concentrations of fasting insulin, nitric oxide (NOx) and intercellular adhesion molecule 1 (ICAM-1). However, the two groups were not significantly different in terms of blood pressure, overall or regional obesity, fasting lipid levels, uric acid, concentrations of other cellular adhesion molecules or levels of C-reactive protein. There were significant (p <0.05) correlations in the whole population between IMT and age, fasting insulin and NOx, and multiple regression analysis identified fasting insulin as an independent predictor of IMT. Conclusions: The presence of increased IMT is significantly related to several metabolic and endothelial abnormalities associated with IR/hyperinsulinemia, and fasting insulin independently predicts the thickness of the intima-media layer. These results support the view that CVD risk is greatest in those patients with essential hypertension who are also IR/hyperinsulinemic.

Original languageEnglish
Pages (from-to)22-27
Number of pages6
JournalNutrition, Metabolism and Cardiovascular Diseases
Volume16
Issue number1
DOIs
Publication statusPublished - Jan 2006

Fingerprint

Tunica Intima
hyperinsulinemia
Hyperinsulinism
insulin resistance
hypertension
Insulin Resistance
Fasting
Insulin
fasting
insulin
cardiovascular diseases
Cardiovascular Diseases
Nitric Oxide
nitric oxide
Essential Hypertension
Intercellular Adhesion Molecule-1
Uric Acid
C-reactive protein
C-Reactive Protein
uric acid

Keywords

  • Essential hypertension
  • Insulin resistance
  • Intima-media thickness

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine (miscellaneous)
  • Food Science
  • Endocrinology, Diabetes and Metabolism

Cite this

Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension. / Zavaroni, Ivana; Ardigò, Diego; Zuccarelli, Alessandra; Pacetti, Edoarda; Piatti, Pier M.; Monti, Lucilla; Valtueña, Silvia; Massironi, Paola; Rossi, Pier C.; Reaven, Gerald M.

In: Nutrition, Metabolism and Cardiovascular Diseases, Vol. 16, No. 1, 01.2006, p. 22-27.

Research output: Contribution to journalArticle

Zavaroni, Ivana ; Ardigò, Diego ; Zuccarelli, Alessandra ; Pacetti, Edoarda ; Piatti, Pier M. ; Monti, Lucilla ; Valtueña, Silvia ; Massironi, Paola ; Rossi, Pier C. ; Reaven, Gerald M. / Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension. In: Nutrition, Metabolism and Cardiovascular Diseases. 2006 ; Vol. 16, No. 1. pp. 22-27.
@article{813c8e2662a14848a8d758fdf04be4db,
title = "Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension",
abstract = "Background and aim: Approximately 50{\%} of subjects with essential hypertension (EH) are insulin resistant, and this defect in insulin action could contribute to increased cardiovascular disease (CVD) risk in these patients. To test this hypothesis, we attempted to see if there was a link between insulin resistance (IR) and carotid intimal medial thickness (IMT), an early index of CVD, in patients with essential hypertension. Methods and results: Ultrasound quantification of carotid IMT was performed in 79 hypertensive patients, and 63 patients (31 m and 32 f), defined as being free of plaque (IMT <1.3 mm), were further subdivided into normal (<1.0 mm) and thickened (1-1.3 mm) IMT groups. Subjects in the thickened IMT group were older and had significantly (p <0.05) higher plasma concentrations of fasting insulin, nitric oxide (NOx) and intercellular adhesion molecule 1 (ICAM-1). However, the two groups were not significantly different in terms of blood pressure, overall or regional obesity, fasting lipid levels, uric acid, concentrations of other cellular adhesion molecules or levels of C-reactive protein. There were significant (p <0.05) correlations in the whole population between IMT and age, fasting insulin and NOx, and multiple regression analysis identified fasting insulin as an independent predictor of IMT. Conclusions: The presence of increased IMT is significantly related to several metabolic and endothelial abnormalities associated with IR/hyperinsulinemia, and fasting insulin independently predicts the thickness of the intima-media layer. These results support the view that CVD risk is greatest in those patients with essential hypertension who are also IR/hyperinsulinemic.",
keywords = "Essential hypertension, Insulin resistance, Intima-media thickness",
author = "Ivana Zavaroni and Diego Ardig{\`o} and Alessandra Zuccarelli and Edoarda Pacetti and Piatti, {Pier M.} and Lucilla Monti and Silvia Valtue{\~n}a and Paola Massironi and Rossi, {Pier C.} and Reaven, {Gerald M.}",
year = "2006",
month = "1",
doi = "10.1016/j.numecd.2004.11.003",
language = "English",
volume = "16",
pages = "22--27",
journal = "Nutrition, Metabolism and Cardiovascular Diseases",
issn = "0939-4753",
publisher = "Elsevier B.V.",
number = "1",

}

TY - JOUR

T1 - Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension

AU - Zavaroni, Ivana

AU - Ardigò, Diego

AU - Zuccarelli, Alessandra

AU - Pacetti, Edoarda

AU - Piatti, Pier M.

AU - Monti, Lucilla

AU - Valtueña, Silvia

AU - Massironi, Paola

AU - Rossi, Pier C.

AU - Reaven, Gerald M.

PY - 2006/1

Y1 - 2006/1

N2 - Background and aim: Approximately 50% of subjects with essential hypertension (EH) are insulin resistant, and this defect in insulin action could contribute to increased cardiovascular disease (CVD) risk in these patients. To test this hypothesis, we attempted to see if there was a link between insulin resistance (IR) and carotid intimal medial thickness (IMT), an early index of CVD, in patients with essential hypertension. Methods and results: Ultrasound quantification of carotid IMT was performed in 79 hypertensive patients, and 63 patients (31 m and 32 f), defined as being free of plaque (IMT <1.3 mm), were further subdivided into normal (<1.0 mm) and thickened (1-1.3 mm) IMT groups. Subjects in the thickened IMT group were older and had significantly (p <0.05) higher plasma concentrations of fasting insulin, nitric oxide (NOx) and intercellular adhesion molecule 1 (ICAM-1). However, the two groups were not significantly different in terms of blood pressure, overall or regional obesity, fasting lipid levels, uric acid, concentrations of other cellular adhesion molecules or levels of C-reactive protein. There were significant (p <0.05) correlations in the whole population between IMT and age, fasting insulin and NOx, and multiple regression analysis identified fasting insulin as an independent predictor of IMT. Conclusions: The presence of increased IMT is significantly related to several metabolic and endothelial abnormalities associated with IR/hyperinsulinemia, and fasting insulin independently predicts the thickness of the intima-media layer. These results support the view that CVD risk is greatest in those patients with essential hypertension who are also IR/hyperinsulinemic.

AB - Background and aim: Approximately 50% of subjects with essential hypertension (EH) are insulin resistant, and this defect in insulin action could contribute to increased cardiovascular disease (CVD) risk in these patients. To test this hypothesis, we attempted to see if there was a link between insulin resistance (IR) and carotid intimal medial thickness (IMT), an early index of CVD, in patients with essential hypertension. Methods and results: Ultrasound quantification of carotid IMT was performed in 79 hypertensive patients, and 63 patients (31 m and 32 f), defined as being free of plaque (IMT <1.3 mm), were further subdivided into normal (<1.0 mm) and thickened (1-1.3 mm) IMT groups. Subjects in the thickened IMT group were older and had significantly (p <0.05) higher plasma concentrations of fasting insulin, nitric oxide (NOx) and intercellular adhesion molecule 1 (ICAM-1). However, the two groups were not significantly different in terms of blood pressure, overall or regional obesity, fasting lipid levels, uric acid, concentrations of other cellular adhesion molecules or levels of C-reactive protein. There were significant (p <0.05) correlations in the whole population between IMT and age, fasting insulin and NOx, and multiple regression analysis identified fasting insulin as an independent predictor of IMT. Conclusions: The presence of increased IMT is significantly related to several metabolic and endothelial abnormalities associated with IR/hyperinsulinemia, and fasting insulin independently predicts the thickness of the intima-media layer. These results support the view that CVD risk is greatest in those patients with essential hypertension who are also IR/hyperinsulinemic.

KW - Essential hypertension

KW - Insulin resistance

KW - Intima-media thickness

UR - http://www.scopus.com/inward/record.url?scp=33645983184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645983184&partnerID=8YFLogxK

U2 - 10.1016/j.numecd.2004.11.003

DO - 10.1016/j.numecd.2004.11.003

M3 - Article

C2 - 16399488

AN - SCOPUS:33645983184

VL - 16

SP - 22

EP - 27

JO - Nutrition, Metabolism and Cardiovascular Diseases

JF - Nutrition, Metabolism and Cardiovascular Diseases

SN - 0939-4753

IS - 1

ER -